{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicollviggy6zqfcx3h4j3gckpkhf42a2dbdvdkjjxulhohxom6avu",
    "uri": "at://did:plc:scbtcug7owbatifs7ovdsyiw/app.bsky.feed.post/3med4z3bgm7s2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreid6eb2t3xkfd4uw3xrtfdjof2jlci557vpdkgdnw27h2z6ecr62ma"
    },
    "mimeType": "image/jpeg",
    "size": 898598
  },
  "path": "/retail/hims-hers-responds-fda-pressure-pulls-knockoff-wegovy-drug-launch-after-regulatory-threats",
  "publishedAt": "2026-02-08T02:51:36.000Z",
  "site": "https://www.foxbusiness.com",
  "tags": [
    "a420dc2f-3fd4-5c00-843f-d40fabf587c9",
    "fbn",
    "Fox Business",
    "fox-business/industries/retail",
    "fox-news/fox-news-health/fox-news-nutrition-and-fitness/fox-news-weight-loss",
    "fox-business/healthcare",
    "fox-business/retail",
    "article"
  ],
  "textContent": "Telehealth company Hims & Hers cancels $49 monthly weight loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats.",
  "title": "Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats"
}